Oryzon

Developer of treatments solutions for cancer and neurodegenerative diseases using epigenetic technology platforms

placeBarcelona, Catalonia, Spain calendar_todayFounded 2000 groups43 employees language oryzon.com

Social engagement

Social engagement: 11.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%

Recent activity

11 Jun 2026
Event
EHA 2026 Annual Congress
21 May 2026
Event
EHA2026
Coming soon